I anxiously looked for AGPH in this story but not to be found...
Execs From 12 Biotech Firms, Analysts Meg Malloy and Eric Schmidt Highlight Informed Investors Boston Biotech Stocks Forum Sept. 15
BusinessWire, Thursday, September 03, 1998 at 13:36
BOSTON--(BW HealthWire)--Sept. 3, 1998--Biotechnology, an
industry poised to drive medical miracles in the next millennium, is
in the spotlight at the First Informed Investors Boston Biotechnology
Stocks Forum Tuesday Sept. 15 at the Back Bay Hilton. The Forum runs
from 8:30 a.m.-4 p.m. The public is welcome.
Also, presentations by executives from 12 publicly-traded biotech
companies, prominent industry analysts Meg Malloy of Hambrecht & Quist
and Eric Schmidt, Ph.D of Cowen & Co. will offer current insight and
perspective on this rapidly-growing and fast-changing industry.
"This is an opportunity for individual investors to gain access
to executives from leading biotechnology companies poised to
revolutionize medical care in the next century," said Steve Chanecka,
President of Sacramento-based Informed Investors. "Not only is the
Forum highly educational, but it gives investors an upfront, personal
look at companies that may become stock market winners in coming
years."
Executives scheduled to give attendees full analyst-style
presentations are: David Hilson, President/CEO, and Dr. Marc Lanser,
Chief Science Officer, Boston Life Sciences (NASDAQ:BLSI); Stuart
Essig, President/CEO, Integra LifeSciences (NASDAQ:IARTD); James
Chamberlain, President/CEO, BioSource International (NASDAQ:BIOI);
Joseph Costello, Chairman/CEO, XOMA Corp. (NASDAQ:XOMA), Tim Surgenor,
President, Genzyme Tissue Repair (NASDAQ:GENZL); Richard Love,
President/CEO, Ilex Oncology (NASDAQ:ILXO); Paul Maier, CFO, Ligand
Pharmaceuticals (NASDAQ:LGND); Dr. Una Ryan, CEO, T Cell Sciences
(NASDAQ:TCEL); Elizabeth Woo, Director of Investor Relations, Biogen
(NASDAQ:BGEN); and Steven Basta, VP/Corp. Development, Creative
BioMolecules (NASDAQ:CBMI). To be announced are executives from
Repligen (NASDAQ:RGEN) and Genzyme Transgenics (NASDAQ:GZTC).
Executives will give 20-25 minute presentations, followed by
question-and-answer period.
The cost to attend is $40 prepaid, $55 at the door (student
rate,$20). Call Informed Investors at 800/992-4683 to register. Audio
tapes will be available for investors unable to attend. The full set
(seven cassettes) are $50 plus $4.95 S/H which includes all company
presentations plus keynote speakers. Individual tapes are $18.
Transcripts of the Malloy's and Schmidt's comments are $25. Access
Informed Investors' website at informedinvestors.com for
more information and updates.
Informed Investors has been holding Forums since 1993 and has
developed into a leading conduit of current financial information from
small and mid-cap growth companies to the retail investor community
(i.e. individual investors). Forums are held throughout the nation and
focus on numerous sectors including biotechnology, technology, growth,
electronics, REITs, software, energy and others. In 1998, Forums have
been held throughout California in Emeryville, Sacramento, San Jose,
San Diego, San Francisco, Santa Clara and Milpitas. Also, Forums have
been held in Boca Raton, Clearwater and Orlando, FL, Seattle, Dallas,
Atlanta, Bethesda, MD, and Englewood, NJ.
"We are pleased with the development of our Forums," commented
Tim Quast, Chief Operating Officer of Informed Investors. "While in
the past we've had large companies participate, such as Intel
(NASDAQ:INTC), Lucent (NYSE:LU), Advanced Micro Devices NYSE:AMD) and
others, we find individual investors are interested in established
companies that may not be well known or covered extensively by Wall
Street analysts. Those are the companies that hold the most
opportunity to find the next Microsoft (NASDAQ:MSFT), Cisco
(NASDAQ:CSCO), Yahoo (NASDAQ:YHOO) or America Online (NYSE:AOL).
"Also, we have a growing base of investors who cannot attend the
Forums but get the next best thing from the audio tapes, video tapes
and transcripts we make available immediately after the Forum," Quast
added. "This works well for companies, too, because we facilitate the
communication of information from them cost effectively. It's a format
that works for both investors and companies. We intend to dramatically
expand our reach in 1999 with more companies in more cities."
On Saturday Sept. 12, Informed Investors is hosting its first
NY/NJ BioPharma Forum in Englewood, N.J. Jim McCamant, Editor of the
Medical Technology Stock Letter (www.bioinvest.com) is the keynote
speaker. Executives presenting are from Genentech (NYSE:GNE),
Immunomedics (NASDAQ:IMMU), Alteon (NASDAQ:ALTN), Organogenesis
(AMEX:ORG), Inhale Therapeutics (NASDAQ:INHL), SunPharm (NASDAQ:SUNP)
and AVI BioPharma (NASDAQ:AVII). Call 800/992-4683 for more
information. Audio tapes are available.
CONTACT: Informed Investors, Inc.
Steve Chanecka, Sean Finnigan, 916/448-8222
or 800/992-4683
KEYWORD: MASSACHUSETTS NEW JERSEY
INDUSTRY KEYWORD: BIOTECHNOLOGY MEDICINE BANKING TRADESHOW
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com
Copyright 1998, Business Wire |
